← Open Payments lookup

NPI 1528037082: Open Payments

NPI 1528037082. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,150 in 113 payments from 14 companies in 2025. Trend: 2023 $1,714 · 2024 $2,238 · 2025 $2,150

Food & beverage: $2,150
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$296
ABBVIE INC.23$280
Alkermes, Inc.11$264
Lundbeck LLC12$218
E.R. Squibb & Sons, L.L.C.10$190
Teva Pharmaceuticals USA, Inc.10$184
Janssen Pharmaceuticals, Inc6$180
Corium, LLC11$172
Axsome Therapeutics, Inc.4$114
Vanda Pharmaceuticals Inc.4$82

Products named: REXULTI, VRAYLAR, COBENFY, Azstarys, SPRAVATO, AUSTEDO XR, LYBALVI, ARISTADA.